Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma;Endocrine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00201838
What this trial is testing

Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsAdenocarcinoma
Ohio State University Comprehensive Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Not applicableStudy completedNCT02952521
What this trial is testing

Ovarian Tumor Biopsies to Study Response to Treatments

Who this might be right for
Epithelial Ovarian Cancer
University Health Network, Toronto 5
Testing effectiveness (Phase 2)Study completedNCT00543049
What this trial is testing

Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor

Who this might be right for
Platinum Refractory Epithelial Ovarian CancerPrimary Cancer of the PeritoneumCancer of the Fallopian Tube
AGO Study Group 73
Early research (Phase 1)WithdrawnNCT03607955
What this trial is testing

Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer
Washington University School of Medicine
Very early researchLooking for participantsNCT07628634
What this trial is testing

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Who this might be right for
AdenocarcinomaBasal Cell CarcinomaSquamous Cell Carcinoma+12 more
University of California, Irvine 25
Not applicableStudy completedNCT02561533
What this trial is testing

Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma
University of Aarhus 53
Large-scale testing (Phase 3)UnknownNCT04055038
What this trial is testing

Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)

Who this might be right for
Ovarian CancerOvarian NeoplasmsSerous Adenocarcinoma+3 more
Blokhin's Russian Cancer Research Center 164
Testing effectiveness (Phase 2)Study completedNCT01666444
What this trial is testing

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Celgene 297
Not applicableLooking for participantsNCT06779747
What this trial is testing

Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology

Who this might be right for
HypothyroidismHyperthyroidism/ThyrotoxicosisThyroid Nodule (Benign)+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 5,850
Large-scale testing (Phase 3)Study completedNCT01460030
What this trial is testing

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Who this might be right for
Parathyroid CarcinomaHypercalcemiaPrimary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT04907851
What this trial is testing

Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

Who this might be right for
Advanced Solid Tumours
Redx Pharma Ltd 45
Testing effectiveness (Phase 2)Study completedNCT00107445
What this trial is testing

EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer

Who this might be right for
Primary Peritoneal Cavity CancerStage I Endometrial CarcinomaStage I Ovarian Epithelial Cancer+13 more
National Cancer Institute (NCI) 60
Not applicableUnknownNCT01522573
What this trial is testing

T-EUS for Gastrointestinal Disorders: A Multicenter Registry

Who this might be right for
CholangiocarcinomaPancreatic CancerBile Duct Cancer+11 more
Weill Medical College of Cornell University 1,000
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Testing effectiveness (Phase 2)Looking for participantsNCT05231122
What this trial is testing

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Clear Cell AdenocarcinomaPlatinum-Sensitive Ovarian CarcinomaRecurrent Endometrial Serous Adenocarcinoma+12 more
Roswell Park Cancer Institute 80
Early research (Phase 1)Active Not RecruitingNCT03017131
What this trial is testing

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Roswell Park Cancer Institute 9
Not applicableLooking for participantsNCT06378905
What this trial is testing

Cukurova Score Validation Study

Who this might be right for
Epithelial Ovarian CancerPrimary Cytoreduction
Cukurova University 130
Not applicableStudy completedNCT03513705
What this trial is testing

Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)

Who this might be right for
Carcinoma, Pancreatic Ductal
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 4,000
Next Page